Letters to the Editor

A targeted gene signature stratifying mediastinal gray zone lymphoma into classical HL-like or PMBL-like subtypes

Hematology and Cell Therapy Unit, IRCCS Istituto Tumori ‘Giovanni Paolo II’, Bari, Italy; Department of Mathematics, University of Bari Aldo Moro, Bari
Hematology and Cell Therapy Unit, IRCCS Istituto Tumori ‘Giovanni Paolo II’, Bari
Department of Mathematics, University of Bari Aldo Moro, Bari
Hematology and Cell Therapy Unit, IRCCS Istituto Tumori ‘Giovanni Paolo II’, Bari
Haematopathology Unit, IRCCS Azienda Ospedaliero-Universitaria di Bologna, Bologna
Haematopathology Unit, IRCCS Azienda Ospedaliero-Universitaria di Bologna, Bologna, Italy; Department of Experimental, Diagnostic and Specialty Medicine, University of Bologna, Bologna
Division of Hematopathology, European Institute of Oncology IRCCS, Milan
Division of Hematopathology, European Institute of Oncology IRCCS, Milan
Ateneo Vita-Salute San Raffaele Milan and Pathology Unit, IRCCS San Raffaele Scientific Institute, Milan
Pathology Unit, Department of Molecular and Translational Medicine, University of Brescia, Brescia
Pathology Unit, Department of Molecular and Translational Medicine, University of Brescia, Brescia
Department of Clinical and Molecular Medicine, Sant’Andrea University Hospital, Sapienza University of Rome, Rome
Department of Molecular Medicine, University of Pavia/Foundation IRCCS Policlinico San Matteo, Pavia
Department of Molecular Medicine, University of Pavia/Foundation IRCCS Policlinico San Matteo, Pavia
Section of Pathology, Department of Medical Biotechnology, University of Siena, Siena
Section of Pathology, Department of Medical Biotechnology, University of Siena, Siena
Pathology Unit, Azienda Ospedaliera Santa Maria di Terni, University of Perugia, Terni
Clinical Pathology and Microbiology Unit, Bonomo Hospital, Andria (BT)
Department of Electrical and Information Engineering (DEI), Polytechnic University of Bari, Bari
Hematology and Cell Therapy Unit, IRCCS Istituto Tumori ‘Giovanni Paolo II’, Bari
Hematology and Cell Therapy Unit, IRCCS Istituto Tumori ‘Giovanni Paolo II’, Bari
Hematology and Cell Therapy Unit, IRCCS Istituto Tumori ‘Giovanni Paolo II’, Bari
Department of Mathematics, University of Bari Aldo Moro, Bari
Hematology and Cell Therapy Unit, IRCCS Istituto Tumori ‘Giovanni Paolo II’, Bari
Hematology and Cell Therapy Unit, IRCCS Istituto Tumori ‘Giovanni Paolo II’, Bari
Hematology and Cell Therapy Unit, IRCCS Istituto Tumori ‘Giovanni Paolo II’, Bari
Department of Pathology, IRCCS Istituto Tumori ‘Giovanni Paolo II’, Bari
Department of Pathology, IRCCS Istituto Tumori ‘Giovanni Paolo II’, Bari
Department of Hematology, Careggi Hospital and University of Florence, Florence
Department of Mathematics, University of Bari Aldo Moro, Bari
Hematology and Cell Therapy Unit, IRCCS Istituto Tumori ‘Giovanni Paolo II’, Bari
Hematology and Cell Therapy Unit, IRCCS Istituto Tumori ‘Giovanni Paolo II’, Bari
Haematologica Early view Jul 18, 2024 https://doi.org/10.3324/haematol.2024.285266